Despite what the name suggests, Polycystic Ovary Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PCOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.
At its core, PCOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PCOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PCOS so challenging—and why understanding your unique experience matters.
So, how can the PCOS Association help?
We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PCOS—and make progress.
Here’s what you’ll find at PCOSA:
✅ Reliable, science-backed information about what PCOS is (and isn’t)
💬 Supportive communities of people who understand exactly what you’re going through
🧬 Resources for navigating fertility, metabolic health, nutrition, and more
🧠 Education for providers who want to better support their PCOS patients
🙋♀️ Advocacy to make sure PCOS is recognized, researched, and respected
No fluff. No fad cures. Just real support, grounded in evidence and compassion.
At PCOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.
pcos: Latest results from PubMed
No abstract
Published on: Mon, 13 Apr 2026 06:00:00 -0400
Authors: Caglar Berkel,
CONCLUSION: Infertility in PCOS is associated with distinct gut microbiota and serum metabolite signatures, characterized by specific microbial taxa shifts and metabolic dysregulation. These findings provide potential biomarkers for clinical stratification and offer insights into the microbiota-metabolite-fertility axis in PCOS.
Published on: Mon, 13 Apr 2026 06:00:00 -0400
Authors: Shen Lin, Shi-Yi Qi, Dan-Ting Ma, Juan Yang, Xue-Li Chen, Tong Lin, Huan-Huan Gao, Hui-Yu Chen, Yu-Nan He, Jie Lin, Jia-Hui Qiu, Di Liu, Jin-Bang Xu,
CONCLUSIONS: There may be benefit to adding probiotics to metformin therapy for women with PCOS in improving insulin resistance and gastrointestinal tolerability as well as possibly decreasing LH. Heterogeneity between studies, short intervention duration and non-standardized probiotic doses/preparations limit the strength of these findings. Further study with larger, longer, randomized controlled trials that use a standardized probiotic formulation are needed.
Published on: Mon, 13 Apr 2026 06:00:00 -0400
Authors: Mohammed Hamsho, Wijdan Shkorfu, Meriem Bensaoua, Carlos Eduardo Carvalho Martins, Hale Hacıbayram, Abdulmannan Fadel, Yazan Ranneh,
CONCLUSION: Adolescent PCOS is significantly associated with an elevated risk of MetS, with abnormalities primarily clustered in abdominal obesity, systolic blood pressure, and triglyceride levels. Integrating these three key metrics into routine metabolic screening for adolescents with PCOS is clinically essential. Prioritizing lifestyle interventions to address these risk factors is critical for mitigating long-term cardiometabolic complications.
Published on: Mon, 13 Apr 2026 06:00:00 -0400
Authors: Yuhui Tu, Yafei Chen, Jianwei Zhang, Jiaping Bao, Jianbo Lou,
Background Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder with complex genetic and neuroendocrine underpinnings. Neuropeptide Y (NPY), a key regulator of energy balance and reproductive function, has been implicated in hypothalamic-pituitary-ovarian (HPO) axis dysregulation. However, data on variants of the NPY gene in PCOS remain limited. This study investigated the association between the NPY promoter variant rs16147 (-399 T/C) and susceptibility to PCOS. Methods In...
Published on: Mon, 13 Apr 2026 06:00:00 -0400
Authors: Fulya Yukcu, Raziye Akcilar, Ismail Biyik, Halil Ibrahim Sisman,
CONCLUSION: Women with PCOS experience poorer body image perception than healthy controls, with no difference in self-esteem. Integrating psychological assessment into PCOS care, and targeted interventions addressing body image concerns may be beneficial. Further large-scale studies across diverse populations using standardized assessment tools are warranted.
Published on: Mon, 13 Apr 2026 06:00:00 -0400
Authors: Hyder Mirghani, Amani Shaman,
CONCLUSION: HA-PCOS is marked by more severe metabolic disruption. Irisin may serve as a promising early biomarker for this phenotype and help predict long-term complications linked to metabolic disruption in PCOS.
Published on: Mon, 13 Apr 2026 06:00:00 -0400
Authors: Sadaf Majeed, Hira Moin, Sampana Fatima, Fasih Hashmi, Tasneem Akhtar, Riffat Shafi,
CONCLUSION: This study identified targets for QFDT in PCOS treatment, helping elucidate the mechanisms of action of this ingredient and its potential clinical applications.
Published on: Mon, 13 Apr 2026 06:00:00 -0400
Authors: Ruye Wang, Yun Chen, Menglei Zhu, Shengyue Jin, Ying Zhao, Chenyun Miao, Ning Ren, Liuqin Yang, Xiaohong Fang, Qin Zhang,
STUDY QUESTION: What are the variations in ovulation time and menstrual cycle characteristics among and within various individuals over the course of 12 menstrual cycles?
Published on: Sun, 12 Apr 2026 06:00:00 -0400
Authors: Maria-Nefeli Malliou-Becher, Pia Maria Herrmann, Alexander Freis, Tanja Freundl-Schütt, Lisa-Maria Wallwiener, Siegfried Baur, Richard J Fehring, Christian Gnoth, Andreas Mallios, Thomas Strowitzki, Petra Frank-Herrmann,
Mammalian reproductive function is dependent upon gonadal steroid hormone feedback within the hypothalamic-pituitary-gonadal (HPG) axis. In polycystic ovary syndrome (PCOS), impaired progesterone (P4) negative feedback leads to hyperactive pulsatile secretion of luteinising hormone (LH) and impaired reproductive function. Although the precise upstream neuronal network modulating P4 negative feedback remains undefined, gamma-aminobutyric acid (GABA)ergic neurons in the arcuate nucleus (ARC) have...
Published on: Sun, 12 Apr 2026 06:00:00 -0400
Authors: Kelly A Glendining, Melanie Prescott, Kyoko Potapov, Elodie Kip, Rebecca E Campbell,
Accurate quantification of circulating androgens, particularly the biologically active free fraction, is analytically challenging due to ultra-low concentrations and extensive protein binding in human serum. Here, we developed and validated an integrated ultrafiltration-LC-MS/MS workflow for simultaneous quantification of nine endogenous serum free androgens. Free fractions were isolated by phosphate-buffered saline dilution followed by temperature-controlled centrifugal ultrafiltration (37 °C)...
Published on: Sun, 12 Apr 2026 06:00:00 -0400
Authors: Xianhua Zhang, Lingling Liu, Huiyu Xu, Xin Xiong, Rongsheng Zhao, Libo Zhao, Rong Li, Li Yang,
5α-androstane-3α,17β-diol 17-glucuronide (3α-diol G) is a testosterone metabolite and an important biomarker of hormonal dysregulation, including polycystic ovary syndrome (PCOS) and virilizing syndromes in women such as idiopathic hirsutism. While immunoassay kits are commonly used for its quantification in clinical laboratories, these methods are prone to interference due to the structural similarity among steroidal compounds. In this study, we developed and validated a robust LC-MS/MS method...
Published on: Sun, 12 Apr 2026 06:00:00 -0400
Authors: André Filipe Rodrigues-Oliveira, Andrea Tedesco Faccio, Gustavo Arantes Rosa Maciel, Karina Helena Morais Cardozo, Valdemir Melechco Carvalho,
Polycystic ovary syndrome (PCOS) is a prevalent and heterogeneous endocrine-metabolic disorder affecting women of reproductive age, characterized by elevated androgen levels, disrupted ovulation, and polycystic ovarian changes. Increasing evidence indicates that oxidative stress and ferroptosis contribute to granulosa cell dysfunction and ovarian impairment in PCOS. In this study, we identified sestrin 2 (SESN2), a stress-inducible metabolic regulator, as a protective factor against ferroptosis...
Published on: Sun, 12 Apr 2026 06:00:00 -0400
Authors: Ying-Ying Li, Ning Xu, Xiao-Yi Gu, Bo Yu, Ying-Yi Luan, Cheng-Hong Yin,
ABSTRACT: Polycystic ovary syndrome (PCOS) is a multifactorial disorder traditionally recognized for its endocrine and metabolic disturbances. However, accumulating evidence indicates that chronic low-grade inflammation and immune dysregulation play a central role in its pathophysiology. This narrative review explores the immunological mechanisms underlying PCOS and their repercussions for reproductive outcomes. Women with PCOS exhibit increased circulating levels of inflammatory...
Published on: Fri, 10 Apr 2026 06:00:00 -0400
Authors: Thaís Bastos Romero, Daniel de Sousa Sobral, Lara Andryne Alves Aguiar, Helena Aben-Athar Ponte, Ricardo Espíndola Romero Filho, Ana Luiza Rangel Montenegro, Marla Girão Ramos Maia, Thiago Gonçalves Marques, Laís de Oliveira Martins, Marcelo Borges Cavalcante,
ImportanceOcular manifestations of polycystic ovarian syndrome (PCOS), particularly related to elevated testosterone, are understudied.ObjectiveTo evaluate prevalence and odds of ocular diseases in PCOS patients using large-scale electronic health records (EHRs).DesignCross-sectional study comparing females aged 15-50 with PCOS (n = 494,557) to two controls: total female population (n = 32,162,331) and BMI ≥30 (n = 4,895,226), based on ICD-10 ocular diagnoses. Prevalence odds ratios (PORs) with...
Published on: Fri, 10 Apr 2026 06:00:00 -0400
Authors: Ana Lopez, Anna Zhang, David C Kaelber, Katherine E Talcott, Rishi P Singh, Jacqueline Shaia,